Switching between pens and pumps
A different way of thinking about insulin, not just of delivering it. What changes in each direction, and why the first weeks are the hardest part.
Moving between pens and a pump is a bigger adjustment than the hardware suggests, in both directions. It is a different way of thinking about insulin rather than a different way of delivering it, and the first few weeks are genuinely harder than either steady state.
- Going onto a pump replaces your long-acting dose with a continuous trickle. There is no reserve behind it.
- Going back to pens returns the reserve, and takes away the fine control you had got used to.
- Neither is better. They suit different people, and different phases of the same life.
- Expect a few unsettled weeks either way, and expect more contact with your team during them.
- Every setting and every dose in a switch is worked out with your diabetes team.
What changes when the long-acting goes away
The headline change is that your background insulin stops being one injection and becomes a continuous delivery of rapid insulin. That is what makes a pump flexible: the background can be different at three in the morning from what it is at three in the afternoon, and it can be turned down for exercise. It is also what makes a failure urgent, since there is no long-acting dose sitting behind it.
The second change is that the arithmetic moves into the device. A pump keeps track of insulin already delivered and suggests amounts based on settings your team programme in, which removes a lot of mental work and introduces a new dependency: the suggestions are only as good as the settings, so the first weeks involve a lot of adjusting.
The third is that you are attached to something. Sleeping, showering, sport, clothing without pockets and being seen all become considerations, and some people find that harder than the clinical side. Tubeless designs solve some of it and not all.
Practically, expect the first month to be busy: frequent contact with the team, settings changing repeatedly, and a period where things behave less predictably than they did on pens. That is the process working rather than going wrong.
Why people go back, and what they get and lose
People move back for reasons that are all legitimate: skin that has had enough of adhesive, sites that are running out, the constant attachment, cost or supply problems, a change in circumstances, or simply preferring it. Going back is not a failure and it is not a step down, though people often expect to be judged for it and occasionally are.
What you get back is simplicity and robustness. A long-acting dose keeps working whatever happens to your kit, there is nothing to fail overnight, and there is nothing attached to you. For some people that is worth more than fine control, and that is a valid trade.
What you lose is the ability to change the background hour by hour, so patterns your pump was quietly handling, such as a dawn rise or an exercise dip, become visible again and need managing differently. Losing the automatic arithmetic is the other adjustment, particularly the insulin-on-board tracking, which is a bigger loss than most people anticipate.
A switch back is not a solo project either. The long-acting dose and the mealtime approach both have to be worked out with your team, and going back abruptly without that is how people end up high for a week.
Making the change go well
Ask what happens if you hate it. Pumps often come with a trial period, and knowing that you can stop takes a great deal of pressure off a decision that otherwise feels permanent. The same applies in reverse: going back to pens does not close the door on pumping later.
Get the plan in writing, both ways. Onto a pump, that means knowing what to do when it fails. Back to pens, it means knowing the timing of the change itself, because there is a handover window where too little or too much insulin is easy to end up with. Both are conversations to have before the day rather than on it.
Then give it longer than a fortnight. Almost everyone finds the first weeks of either direction harder than the thing they left, and judging the decision from inside that period is judging the transition rather than the destination. Book the follow-up contact in advance so support is scheduled rather than requested, and say early rather than late if it is not going well.
What the decision usually turns on
How much your insulin needs vary across the day is the strongest clinical argument for a pump, since that is the thing pens cannot follow. Skin and sites is the commonest reason people move the other way. And how you feel about wearing something is a legitimate deciding factor rather than a soft one.
What the transitions feel like
Examples, not instructions or doses.
Settings changing weekly and everything less predictable than on pens. That is the process working, not a sign the decision was wrong.
A dawn rise the pump had been quietly handling, visible again on pens. Not new, just no longer absorbed by the background.
Coming off a pump without agreeing the timing, and a week of highs through the handover. A conversation before the day rather than on it.